---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-000714"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2026-02-09T23:59:59+00:00"
generated_at: "2026-05-16T04:01:12.600777+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# VolitionRx receives NYSE American non-compliance notice for stockholders' equity; must submit plan by March 8, 2026

## Summary
- Received NYSE American notice on Feb 6, 2026 for failing $2M, $4M, $6M stockholders' equity thresholds due to sustained losses.
- Must submit compliance plan by March 8, 2026; deadline to regain compliance is August 6, 2027.
- Stock will trade under VNRX with ".BC" designation indicating "below compliance."
- If plan not submitted or accepted, NYSE American will commence delisting proceedings.
- No immediate impact on listing or business operations; company intends to submit a plan.

## SEC filing metadata
- accession: 0001477932-26-000714
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2026-02-09T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793226000714/0001477932-26-000714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793226000714/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-000714
- JSON: https://secwatch.observer/filing/0001477932-26-000714.json
- Plain text: https://secwatch.observer/filing/0001477932-26-000714.txt

## Key facts
- Listing & Compliance Notices
  VOLITIONRX LTD received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii), 1003(a)(iii)).
  - Exchange: nyse american
  - Notice: noncompliance notice
  - Deficiency: stockholders equity
  - Rules: 1003(a)(i), 1003(a)(ii), 1003(a)(iii)
  source text: February 6, 2026, VolitionRx Limited (the “Company”) received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders’ equit
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793226000714/0001477932-26-000714-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.